Literature DB >> 11714717

Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. Implication for inflammation-associated carcinogenesis.

Yoshimasa Nakamura1, Qing Feng, Takeshi Kumagai, Koji Torikai, Hajime Ohigashi, Toshihiko Osawa, Noriko Noguchi, Etsuo Niki, Koji Uchida.   

Abstract

Ebselen, a seleno-organic compound showing glutathione peroxidase-like activity, is one of the promising synthetic antioxidants. In the present study, we investigated the antioxidant activities of ebselen using a 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated mouse skin model. Double pretreatments of mouse skin with ebselen significantly inhibited TPA-induced formation of thiobarbituric acid-reacting substance, known as an overall oxidative damage biomarker, in mouse epidermis, suggesting that ebselen indeed acts as an antioxidant in mouse skin. The antioxidative effect of ebselen is attributed to its selective blockade of leukocyte infiltration and activation leading to attenuation of the H(2)O(2) level. In in vitro studies, ebselen inhibited TPA-induced superoxide generation in differentiated HL-60 cells and lipopolysaccharide-induced cyclooxygenase-2 protein expression in RAW 264.7 cells. In addition, we demonstrated for the first time that ebselen potentiated phase II enzyme activities, including NAD(P)H:(quinone-acceptor) oxidoreductase1 and glutathione S-transferase in cultured hepatocytes and in mouse skin. These results strongly suggest that ebselen, a multifunctional antioxidant, is a potential chemopreventive agent in inflammation-associated carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714717     DOI: 10.1074/jbc.M109641200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen.

Authors:  Jade B Aitken; Peter A Lay; T T Hong Duong; Roshanak Aran; Paul K Witting; Hugh H Harris; Barry Lai; Stefan Vogt; Gregory I Giles
Journal:  J Biol Inorg Chem       Date:  2012-02-11       Impact factor: 3.358

2.  Toward pyridine-fused selenium-containing antioxidants.

Authors:  Tahli Fenner; Carl H Schiesser
Journal:  Molecules       Date:  2004-05-31       Impact factor: 4.411

Review 3.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

Review 4.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

5.  Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  June-Wha Rhee; Hyoju Yi; Dilip Thomas; Chi Keung Lam; Nadjet Belbachir; Lei Tian; Xulei Qin; Jessica Malisa; Edward Lau; David T Paik; Youngkyun Kim; Beatrice SeungHye Choi; Nazish Sayed; Karim Sallam; Ronglih Liao; Joseph C Wu
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

Review 6.  Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.

Authors:  M Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma.

Authors:  Ujjawal H Gandhi; Naveen Kaushal; Kodihalli C Ravindra; Shailaja Hegde; Shakira M Nelson; Vivek Narayan; Hema Vunta; Robert F Paulson; K Sandeep Prabhu
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

8.  Neuroprotection against neuroblastoma cell death induced by depletion of mitochondrial glutathione.

Authors:  Vikas V Dukhande; Ivana Kawikova; Alfred L M Bothwell; James C K Lai
Journal:  Apoptosis       Date:  2013-06       Impact factor: 4.677

9.  Ebselen abrogates TNFalpha induced pro-inflammatory response in glioblastoma.

Authors:  Richa Tewari; Vivek Sharma; Nitin Koul; Abhishek Ghosh; Christy Joseph; Ugir Hossain Sk; Ellora Sen
Journal:  Mol Oncol       Date:  2008-11-05       Impact factor: 6.603

10.  Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status.

Authors:  Joshua Jabaut; Jennifer L Ather; Alexandra Taracanova; Matthew E Poynter; Karina Ckless
Journal:  Free Radic Biol Med       Date:  2013-01-29       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.